753 related articles for article (PubMed ID: 27763259)
1. Antifungal Drugs: The Current Armamentarium and Development of New Agents.
Robbins N; Wright GD; Cowen LE
Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763259
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial strategies for combating invasive fungal infections.
Spitzer M; Robbins N; Wright GD
Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
[TBL] [Abstract][Full Text] [Related]
3. Antifungal Drug Resistance: Molecular Mechanisms in
Lee Y; Puumala E; Robbins N; Cowen LE
Chem Rev; 2021 Mar; 121(6):3390-3411. PubMed ID: 32441527
[TBL] [Abstract][Full Text] [Related]
4. Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ellis EC; Lin J; Lin X; Lewis ZA; Meagher RB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666315
[No Abstract] [Full Text] [Related]
5. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
6. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
[TBL] [Abstract][Full Text] [Related]
7. Elucidating drug resistance in human fungal pathogens.
Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
[TBL] [Abstract][Full Text] [Related]
8. Antifungals.
Campoy S; Adrio JL
Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
[TBL] [Abstract][Full Text] [Related]
9. Antifungal drug resistance: evolution, mechanisms and impact.
Revie NM; Iyer KR; Robbins N; Cowen LE
Curr Opin Microbiol; 2018 Oct; 45():70-76. PubMed ID: 29547801
[TBL] [Abstract][Full Text] [Related]
10. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
[TBL] [Abstract][Full Text] [Related]
11. Development and research progress of anti-drug resistant fungal drugs.
Cui X; Wang L; Lü Y; Yue C
J Infect Public Health; 2022 Sep; 15(9):986-1000. PubMed ID: 35981408
[TBL] [Abstract][Full Text] [Related]
12. Molecular Evolution of Antifungal Drug Resistance.
Robbins N; Caplan T; Cowen LE
Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
[TBL] [Abstract][Full Text] [Related]
13. Current status of antifungal resistance and its impact on clinical practice.
Alcazar-Fuoli L; Mellado E
Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
[TBL] [Abstract][Full Text] [Related]
14. Potential targets for the development of new antifungal drugs.
Su H; Han L; Huang X
J Antibiot (Tokyo); 2018 Nov; 71(12):978-991. PubMed ID: 30242283
[TBL] [Abstract][Full Text] [Related]
15. Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.
Thammahong A; Puttikamonkul S; Perfect JR; Brennan RG; Cramer RA
Microbiol Mol Biol Rev; 2017 Jun; 81(2):. PubMed ID: 28298477
[TBL] [Abstract][Full Text] [Related]
16. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach WJ; Reedy JL; Cramer RA; Perfect JR; Heitman J
Nat Rev Microbiol; 2007 Jun; 5(6):418-30. PubMed ID: 17505522
[TBL] [Abstract][Full Text] [Related]
17. Targeting virulence: a new paradigm for antifungals.
Gauwerky K; Borelli C; Korting HC
Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
[TBL] [Abstract][Full Text] [Related]
18. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.
Cowen LE; Singh SD; Köhler JR; Collins C; Zaas AK; Schell WA; Aziz H; Mylonakis E; Perfect JR; Whitesell L; Lindquist S
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2818-23. PubMed ID: 19196973
[TBL] [Abstract][Full Text] [Related]
19. Systemic Antifungal Agents: Current Status and Projected Future Developments.
Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
[TBL] [Abstract][Full Text] [Related]
20. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
Georgopapadakou NH
Expert Opin Investig Drugs; 2002 Aug; 11(8):1117-25. PubMed ID: 12150705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
